NDC 87625-110 - SurviveX Travel Med MOD
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 87625-110
- Manufacturer
- Intent Brands LLC
- Effective date
- 2026-08-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SurviveX Travel Med MOD - Intent Brands LLC | Intent Brands LLC | 2026-08-04 | HUMAN OTC DRUG LABEL |
| SurviveX Travel Med Kit - Intent Brands LLC | Intent Brands LLC | 2026-05-07 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hemorrhoidal | COCOA BUTTER, PHENYLEPHRINE HYDROCHLORIDE | GRAXCELL PHARMACEUTICAL, LLC | 5162baee-0d63-494e-8046-459437b85348 | 2025-12-25 | Warnings | 04JA59TNSJ |
| Pharbetol | ACETAMINOPHEN | Pharbest Pharmaceuticals, Inc. | 04dbd98f-c74d-43b2-8bda-74f18be7cf6c | 2025-12-24 | Warnings | M013 362O9ITL9D |
| CETAFEN EXTRA | ACETAMINOPHEN | HART Health | 38db0b09-37f8-4fed-903e-81e89486b39b | 2025-12-24 | Warnings | 362O9ITL9D |
| Pharbedryl | DIPHENHYDRAMINE HCL | Pharbest Pharmaceuticals, Inc. | 070e556b-e083-452f-8a7c-aca92470dd61 | 2025-12-24 | Warnings | TC2D6JAD40 |
| GUAIFENESIN | GUAIFENESIN | Pharbest Pharmaceuticals, Inc. | 0bf70fb4-d3c8-476d-b864-4eadc697a7d8 | 2025-12-24 | Warnings | M012 |
| PHARBEDRYL | DIPHENHYDRAMINE HCL | Pharbest Pharmaceuticals, Inc. | a19f1edc-d2cf-45fc-8233-d882441b0247 | 2025-12-24 | Warnings | TC2D6JAD40 |
| CETAFEN | ACETAMINOPHEN | HART Health | c1162bab-377d-4e17-9417-ccd20d29148b | 2025-12-24 | Warnings | 313782 362O9ITL9D |
| Adult Low Dose Aspirin Enteric Coated | ASPIRIN 81MG | Pharbest Pharmaceuticals, Inc. | 45e5bae9-22a7-4699-85ea-5b922af6b96d | 2025-12-24 | Warnings | M013 R16CO5Y76E |
| Ibuprofen | IBUPROFEN | Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd | 46a9424c-fd7d-f88b-e063-6294a90abceb | 2025-12-24 | Warnings | WK2XYI10QM |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Redpharm Drug | 37457bd5-2fdd-b829-e063-6294a90a04f0 | 2025-12-24 | Warnings, Adverse reactions | 995666 HDP7W44CIO |
| Gas Relief | SIMETHICONE | H-E-B | 3f9f6560-312f-44b7-e063-6394a90a1c56 | 2025-12-24 | Warnings | M001 |
| Aspirin 325 mg | ASPIRIN | BETTER LIVING BRANDS, LLC | 424a242f-c8c6-9dd7-e063-6394a90ab4d5 | 2025-12-24 | Warnings | M013 212033 R16CO5Y76E |
| Zegerid OTC | OMEPRAZOLE, SODIUM BICARBONATE | Riley Consumer Care LLC | 1d764fc5-8eae-4fc9-a2e9-3f1954a3ac05 | 2025-12-24 | Warnings | 8MDF5V39QO |
| CETAFEN COUGH and COLD | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL , GUAIFENESIN, , | HART Health | 44da0d8c-4a12-4122-99da-781e2809e1a8 | 2025-12-24 | Warnings | 04JA59TNSJ 362O9ITL9D |
| Low Dose Aspirin | ASPIRIN | Pharbest Pharmaceuticals, Inc. | 2763a733-d617-4d95-8429-fbf81d9d77fb | 2025-12-24 | Warnings | M013 R16CO5Y76E |
| Adult Low Dose Aspirin | ASPIRIN | Pharbest Pharmaceuticals, Inc. | 4522f745-b88d-4021-a5dc-0161f1967dc9 | 2025-12-24 | Warnings | R16CO5Y76E |
| Pharbetol Regular strength | ACETAMINOPHEN | Pharbest Pharmaceuticals, Inc. | e0a39957-d918-4125-88f9-0e550b976fa1 | 2025-12-24 | Warnings | M013 313782 362O9ITL9D |
| MECLIZINE | MECLIZINE HCL 12.5 MG | Pharbest Pharmaceuticals, Inc. | 8b3c9283-b618-4d57-9f15-7cf73e8737f5 | 2025-12-24 | Warnings | M009 HDP7W44CIO |
| PHARBETOL | ACETAMINOPHEN 500MG | Pharbest Pharmaceuticals, Inc. | 27337be9-e279-460e-903e-ae4463099599 | 2025-12-24 | Warnings | M013 362O9ITL9D |
| MECLIZINE | MECLIZINE HCL 25MG | Pharbest Pharmaceuticals, Inc. | 4bac2765-045c-405e-8006-8c5cfdfa89bc | 2025-12-24 | Warnings | M009 HDP7W44CIO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.